Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
fda
3
×
life sciences
national blog main
national top stories
biotech
boston top stories
new york blog main
san francisco blog main
abbvie
akili interactive labs
alkermes
allergan
boston
bruce leuchter
buprenorphine
cancer
cancer immunotherapy
cariprazine
center for medicare and medicaid services
click therapeutics
clickotine
clinical trials
companion diagnostic
daniel o'day
david benshoof klein
david klein
deals
digital health
digital medicines
digital therapeutics
eli lilly
europe
europe blog main
europe top stories
felipe jain
foundation medicine
foundationone cdx
foundationone heme
genentech
What
gain
3
×
medicine
drug
momentum
vote
acquire
agreed
alkermes
announced
antipsychotic
backs
benefits
bets
big
billion
broad
caveats
click
commonly
confidence
designed
didn’t
digital
effect
example
favor
fda
field
foundation
genentech
grabbed
latest
makers
making
medicines
monday
morning
nascent
offer
panel
Language
unset
Current search:
gain
×
fda
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
